Vienna, Austria

Andreas Zoephel


Average Co-Inventor Count = 17.9

ph-index = 2

Forward Citations = 13(Granted Patents)


Company Filing History:


Years Active: 2010-2012

Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Andreas Zoephel

Introduction

Andreas Zoephel is a prominent inventor based in Vienna, Austria. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that target diseases characterized by excessive or abnormal cell proliferation. With a total of 3 patents to his name, Zoephel's work is recognized for its potential impact on pharmaceutical applications.

Latest Patents

Zoephel's latest patents include innovative compounds such as 4-heterocycloalkylpyri(mi)dines, which are designed for use as medicaments. These compounds are characterized by a general formula that allows for the treatment of various diseases. Another notable patent involves thiazolyl-dihydro-indazoles, which also fall under the category of compounds with significant therapeutic potential.

Career Highlights

Throughout his career, Zoephel has been associated with Boehringer Ingelheim International GmbH, a leading global pharmaceutical company. His work at this esteemed organization has allowed him to focus on the development of novel therapeutic agents that address critical health challenges.

Collaborations

Zoephel has collaborated with notable colleagues in his field, including Ralph Brueckner and Thomas Gerstberger. These partnerships have fostered a collaborative environment that enhances the innovation process and leads to the development of groundbreaking medicinal compounds.

Conclusion

Andreas Zoephel's contributions to medicinal chemistry and his innovative patents underscore his role as a key figure in the pharmaceutical industry. His work continues to pave the way for advancements in the treatment of diseases, showcasing the importance of innovation in healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…